may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful. feedback to editors.
cancer patients� lives are being put at risk because savage tory cuts to the nhs are delaying the start of their treatment by 18 months...: "targeted cgrp small molecule antagonists for acute migraine therapy.".